Cardiac AI: The Billion Dollar Split Between Detection and Prevention
People talk about AI in cardiology like it’s one big thing, a catch-all for everything from souped-up imaging…
Hypertension: The Billion Dollar Gateway to Cardiac Prevention
Cardiovascular disease is a huge problem, and we need new prevention strategies that can actually scale. People often…
Mapping the Future: Consumer ECGs & Cardiac AI Investment
AI and consumer-grade electrocardiogram (ECG) devices have completely changed the game in cardiac screening and monitoring. What started…
Remote Cardiac AI: Unlocking the Billion-Dollar Reimbursement Playbook
Cardiac diagnostics is changing fast, thanks to artificial intelligence and the big move toward long-term remote monitoring. If…
Cardiac AI: Why Detection Wins 90% of Investment
If you follow the money in cardiac AI, it flows in two completely different directions. The capital reveals…
Cardiac AI: The Billion Dollar Split in Detection & Prevention
When you look at AI in cardiology, you’re really looking at two completely different jobs: finding heart disease…
FFRct: From FDA De Novo to Billion Dollar Routine Referral
Getting a new cardiac diagnostic from a research paper into a routine clinical referral is anything but a…
Plaque Quantification: De-Risking Cardiac AI for Investors
Cardiovascular AI is moving fast, thanks to better imaging and computing, but for those of us actually running…
Hypertension: The Billion-Dollar Entry Point for Cardiac AI
We’re missing a huge opportunity with hypertension. We tend to see it as just another comorbidity, but it’s…
Cardiac AI: The Billion Dollar Paradox of Detection vs. Prevention
There’s a paradox at the heart of AI in cardiology, and if you’re an investor or a prevention…